Rising prevalence of chronic diseases, increasing number of pharmaceutical and biopharmaceutical companies globally, and technological developments in cell-based assays are some key factors fueling growth of the global cell-based assays market
The global cell-based assays market size is expected to reach USD 28.2 Billion by 2028 and register a CAGR of 8.5% over the forecast period, according to the latest report by Reports and Data. Some key factors such as growing funding by public and private sectors and increasing utilization of cell-based assays in drug discovery are driving global market revenue growth.
Cell-based assay is a technique used for analyzing living cells based on various parameters and also aids in measuring cell toxicity, motility, proliferation in diagnostics and drug discovery. High demand for cell-based assays in drug discovery and development is rapidly escalating revenue growth. Moreover, technological developments in cell-based assays, and rising adoption of 3D-based cell assays, and increasing need for developing biologically relevant substitutes for drug discovery are some significant factors boosting market growth.
Overall high cost of assays due to high maintenance and instrument costs, lack of skilled professionals, and stringent regulations on reagent usage are some key factors expected to hamper growth of the cell-based assays market to some extent throughout the forecast period.
Leading companies operating in the market and profiled in the report include:
Danaher Corporation (US), Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), PerkinElmer, Inc. (US), Promega Corporation (US), Charles River Laboratories (US), Lonza (Switzerland), BioAgilytix Labs (US), Reaction Biology Corporation (US), and AAT Bioquest (US).
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3997
Market Dynamics:
The pharma & healthcare sectors has been rapidly growing over the last few decades. Technological advancements in healthcare sector, emergence of various diseases, COVID-19 outbreak are key factors boosting global market revenue growth. The global Cell-based Assays market is expected to reach USD XX Billion in 2028 from USD XX Billion in 2020 at a CAGR of XX%. Growing need to develop new drugs and medical devices to cater to emerging diseases, high investments in research and development activities, and improvements in healthcare infrastructure and facilities is expected to fuel global market growth over the forecast period. In addition, adoption of AI in various healthcare application, funding from various private and public organizations to boost research activities in pharmaceutical and biotechnology sector and vaccine production during the current pandemic situation is also expected to boost market growth.
Order this report @ https://www.reportsanddata.com/report-pricing/3997
Competitive Landscape:
Dominant key players in the market are adopting various strategies like mergers and acquisition, partnerships, collaborations, joint ventures and product launches to gain a robust footing in the market. Growing demand for various medical products, increasing adoption of home-care settings, point-of-care diagnosis, high demand for vaccines and medication for controlling COVID-19 is expected to benefit the key companies throughout the forecast period.
Global Cell-based Assays Market Segmentation:
Type Outlook:
Based On Product And Service (Revenue, USD Billion, 2018 - 2028)
- Consumables
- Reagents
- Assay Kits
- Reporter Gene Assays
- Cell Growth Assays
- Second Messenger Assays
- Cell Death Assays
- Other Assay Kits
- Cell Lines
- Immortalized Cell Lines
- Primary Cell Lines
- Stem Cell Lines
- Microplates
- Probes & Labels
- Other Consumables
- Instruments & Software
- Services
Based On Application: (Revenue, USD Billion, 2018 - 2028)
- Drug Discovery
- Toxicity Studies
- Pharmacodynamics Studies
- Pharmacokinetic Studies
- Basic Research
- Other Applications
Based On End Use: (Revenue, USD Billion, 2018 - 2028)
- Pharmaceutical & Biopharmaceutical Companies
- CROs
- Academic & Research Institutes
The global Cell-based Assays market is broadly divided into 5 major regions, viz. North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Regional Outlook:
- North America
- S.
- Canada
- Mexico
- Europe
- Germany
- K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- A.E.
- South Africa
- Rest of MEA
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3997
Thank you reading our reading. Kindly note that we also offer customized report as per client’s requirement. Feel free to contact us to know more about the customization feature and get your customized report.
Browse More Reports:
Preparative and Process Chromatography Market @ https://www.biospace.com/article/preparative-and-process-chromatography-market-analysis-development-opportunities-future-growth-and-business-prospects-by-forecast-to-2028/
Nanoparticle Drug Delivery Systems Market @ https://www.biospace.com/article/nanoparticle-drug-delivery-systems-market-insights-future-trends-on-going-demand-opportunities-segmentation-and-forecast-till-2028/
Orthopedic Surgery Navigation Software Market @ https://www.biospace.com/article/orthopedic-surgery-navigation-software-market-share-size-key-players-trends-competitive-and-regional-forecast-to-2028/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
